Sections

Home | Cancers | Lung Cancer

Lung Cancer

Scientists step closer to halting spread of lung cancer

Scientists at the Universities of York and Texas have found that a component of cancer cells, which acts like a ‘cellular post ...

Mutant Protein Linked to Spread of Lung Cancer Within the Body

Research Suggests New Treatment Strategy for Deadly Metastatic Cancer ...

Blood test could predict best treatment for lung cancer

A blood test could predict how well small-cell lung cancer (SCLC) patients will respond to treatment, according to new research published in Nature Medicine today. ... Full story

Before a cure, a crusade to stop lung cancer from spreading

The American Cancer Society has reported that lung cancer, which kills more Americans than any other type of cancer, is expected to result in an estimated 158,080 deaths in 2016. ... Full story

Smoking a pack a day for a year causes 150 mutations in lung cells

Scientists have measured the catastrophic genetic damage caused by smoking in different organs of the body and identified several different mechanisms by which tobacco smoking ... Full story

Beta-cryptoxanthin, a carotenoid, inhibits nicotine-linked lung cancer development in mice

New study finds that beta-cryptoxanthin, a carotenoid found primarily in red, orange and yellow-colored fruits and vegetables, reduces lung cancer development and invasiveness in mouse and cell models ... Full story

VICC trial putting lung cancer therapy to the test

Vanderbilt-Ingram Cancer Center (VICC) is leading a Phase 3 global trial of a cancer therapy that was initially tested and validated in a VICC research laboratory. One of the first patients treated with the therapy came to VICC after a bump on the head led to an unexpected cancer diagnosis. ... Full story

Pembrolizumab New Option for First Line Treatment of Patients with Advanced Lung Cancer and High PD-L1 Expression

LUGANO-COPENHAGEN – Pembrolizumab is set to become a new option for first line treatment of patients with advanced lung cancer and high PD-L1 expression, according to the results of the phase III KEYNOTE-024 trial presented at the ESMO 2016 Congress in Copenhagen and published in the New England Journal of Medicine. ... Full story

Neoadjuvant Immunotherapy Prior to Surgery is Safe and Feasible in Early Lung Cancer

LUGANO-COPENHAGEN – Neoadjuvant immunotherapy with the PD-1 inhibitor nivolumab is safe and feasible prior to surgery for early lung cancer, researchers reported at the ESMO 2016 Congress in Copenhagen. ... Full story

Study identifies new way to suppress lung tumors

By Ziba Kashef Changes in cell distribution for growth promoting proteins (EGFR;red) when addition of sugar chains is decreased by the inhibitor, NGI-1. Proteins without sites ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 209 | displaying: 1 - 10